Search results summary

From Health Canada

Search criteria

  • Status: Select all
  • AIG: 0262970001

Search results

List of returned drug products
Products returned by the search are listed, including their status, DIN number, name, class, total count of active ingredients and the name of one, etc. Clicking on the value in the DIN column returns more complete information about the related product.
Status DIN Company Product Class PM See footnote1 Schedule # See footnote2 A.I. name See footnote3 Strength
Authorized By Interim Order 02516691 HOFFMANN-LA ROCHE LIMITED CASIRIVIMAB AND IMDEVIMAB Human Yes Prescription 2 CASIRIVIMAB 300 MG / 2.5 ML
Authorized By Interim Order 02516691 HOFFMANN-LA ROCHE LIMITED CASIRIVIMAB AND IMDEVIMAB Human Yes COVID-19 - IO - Authorization 2 CASIRIVIMAB 300 MG / 2.5 ML
Authorized By Interim Order 02516691 HOFFMANN-LA ROCHE LIMITED CASIRIVIMAB AND IMDEVIMAB Human Yes Schedule D 2 CASIRIVIMAB 300 MG / 2.5 ML
Marketed 02516705 HOFFMANN-LA ROCHE LIMITED CASIRIVIMAB AND IMDEVIMAB Human Yes COVID-19 - IO - Authorization 2 CASIRIVIMAB 1332 MG / 11.1 ML
Marketed 02516705 HOFFMANN-LA ROCHE LIMITED CASIRIVIMAB AND IMDEVIMAB Human Yes Prescription 2 CASIRIVIMAB 1332 MG / 11.1 ML
Marketed 02516705 HOFFMANN-LA ROCHE LIMITED CASIRIVIMAB AND IMDEVIMAB Human Yes Schedule D 2 CASIRIVIMAB 1332 MG / 11.1 ML
Version 4.0.2
Date modified: